𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Collecting quality of life data in EORTC clinical trials—what happens in practice?

✍ Scribed by Teresa Young; Jane Maher

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
41 KB
Volume
8
Category
Article
ISSN
1057-9249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life as an endpoint in EORTC
Quality of life as an endpoint in EORTC clinical trials
✍ Gwendoline M. Kiebert; Desmond Curran; Neil K. Aaronson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

For more than 30 years the European Organization for Research and Treatment for Cancer (EORTC) has conducted, co-ordinated, and stimulated research on the experimental and clinical bases of treatment of cancer and related problems. For more than a decade the EORTC has included quality of life as an

Item response models for longitudinal qu
Item response models for longitudinal quality of life data in clinical trials
✍ Jeffrey A. Douglas 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Assessment of quality of life is becoming standard in clinical trials. A popular method for measuring quality of life is with instruments which utilize multiple-item subscales, in which each item is scored on a Likert scale. Most statistical methods for the analysis of quality of life data in clinic

Statistical analysis of quality of life
Statistical analysis of quality of life with missing data in cancer clinical trials
✍ Andrea B. Troxel; Diane L. Fairclough; Desmond Curran; Elizabeth A. Hahn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud

Identifying the types of missingness in
Identifying the types of missingness in quality of life data from clinical trials
✍ D. Curran; M. Bacchi; S. F. Hsu Schmitz; G. Molenberghs; R. J. Sylvester 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 1 views

This paper discusses methods of identifying the types of missingness in quality of life (QOL) data in cancer clinical trials. The first approach involves collecting information on why the QOL questionnaires were not completed. Based on the reasons provided one may be able to distinguish the mechanis

Missing quality of life data in cancer c
Missing quality of life data in cancer clinical trials: serious problems and challenges
✍ Jürg Bernhard; David F. Cella; Alan S. Coates; Lesley Fallowfield; Patricia A. G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor

Incomplete quality of life data in rando
Incomplete quality of life data in randomized trials: missing items
✍ Peter M. Fayers; Desmond Curran; David Machin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

Missing data has been a problem in many quality of life studies. This paper focuses upon the issues involved in handling forms which contain one or more missing items, and reviews the alternative procedures. One of the most widely practised approaches is imputation using the mean of all observed ite